Triathlon PSR Tibial Insert for Knee Replacement
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new knee insert called the Triathlon PSR Tibial Insert, designed to improve outcomes for people undergoing total knee replacement surgery. The researchers aim to determine if this new insert performs as well as older versions, helping patients regain mobility and reduce pain. It suits those with non-inflammatory degenerative joint disease, such as osteoarthritis, who are planning their first knee replacement surgery. Participants must adhere to a follow-up routine after surgery to track their progress. As an unphased trial, this study offers patients the opportunity to contribute to valuable research that could enhance future knee replacement outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are taking steroids in excess of normal physiological requirements, you may not be eligible to participate.
What prior data suggests that the Triathlon PSR Tibial Insert is safe for primary total knee arthroplasty?
Research has shown that the Triathlon PSR Tibial Insert, used in knee replacement surgeries, is generally safe for patients. Studies have found that patients tolerate this device well, with few problems. Available data reports no serious side effects or major complications.
Testing has confirmed the device's effectiveness and safety, and it is approved for use in knee surgeries, meeting safety standards for medical devices. The design of the Triathlon PSR Tibial Insert aims to allow more natural knee movement, reducing discomfort.
Overall, safety data supports the Triathlon PSR Tibial Insert as a reliable option for those undergoing knee replacement surgery.12345Why are researchers excited about this trial?
The Triathlon PSR Tibial Insert is unique because it offers a more personalized approach to knee replacement. Unlike standard tibial inserts, which often come in a fixed shape and size, the Triathlon PSR Tibial Insert is designed to fit more precisely with a patient's knee anatomy. This could potentially lead to better joint stability and a more natural range of motion. Researchers are excited about this treatment because it may improve patient outcomes by reducing wear and tear on the joint and enhancing overall comfort and mobility after surgery.
What evidence suggests that the Triathlon PSR Tibial Insert is effective for total knee arthroplasty?
Research has shown that the Triathlon Total Knee System, including the Triathlon PSR Tibial Insert under study in this trial, performs well over time. One study found that 95.4% of these knee replacements functioned properly 10 years after surgery, indicating successful outcomes for most patients a decade later. Another study reported that patients with the Triathlon knee replacement experienced significant pain relief and improved knee function. These findings suggest that the Triathlon PSR Tibial Insert effectively enhances knee replacement outcomes.56789
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
Participants undergo pre-operative assessments including EQ-5D and SF-36 questionnaires
Treatment
Participants receive the Triathlon Total Knee System with the Triathlon PSR Tibial Insert
Follow-up
Participants are monitored for safety and effectiveness, including assessments at 6 weeks and 1 year
Long-term Follow-up
Survivorship of the Triathlon PSR Insert is evaluated over a 10-year period
What Are the Treatments Tested in This Trial?
Interventions
- Triathlon PSR Tibial Insert
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stryker Orthopaedics
Lead Sponsor
Kevin A. Lobo
Stryker Orthopaedics
Chief Executive Officer since 2012
Bachelor's degree in Commerce from McGill University, MBA from University of Toronto
Dr. Jorge Enrique Diaz
Stryker Orthopaedics
Chief Medical Officer since 2023
MD from University of Michigan Medical School